Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
NTRA
|
Michael Burkes Brophy
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,886 Reduced 1.82% |
$333,067
$176.6 p/Share
|
Jan 31
2025 |
|
NTRA
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct | 163 Reduced 0.06% |
$28,785
$176.6 p/Share
|
Jan 31
2025 |
|
TEM
|
Ryan M Bartolucci
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 13,770 Reduced 19.39% |
$826,200
$60.0 p/Share
|
Jan 31
2025 |
|
TEM
|
Eric P Lefkofsky
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 82,056 Reduced 1.46% |
$4,831,457
$58.88 p/Share
|
Jan 31
2025 |
|
ARDX
|
Michael Raab
President & CEO |
SELL
Open market or private sale
|
Direct | 41,666 Reduced 3.62% |
$223,329
$5.36 p/Share
|
Jan 31
2025 |
|
SKYH
|
Boston Omaha Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 4,405 Reduced 0.04% |
$48,587
$11.03 p/Share
|
Jan 31
2025 |
|
WEAV
|
Blake G Modersitzki |
SELL
Open market or private sale
|
Indirect | 103,620 Reduced 0.0% |
$1,712,838
$16.53 p/Share
|
Jan 31
2025 |
|
PCAR
|
Darrin C Siver
EXECUTIVE VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 103,671 Reduced 62.95% |
$11,565,536
$111.56 p/Share
|
Jan 31
2025 |
|
PCAR
|
Todd R Hubbard
VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 26.8% |
$224,100
$112.05 p/Share
|
Jan 31
2025 |
|
PCAR
|
R Preston Feight
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 25,200 Reduced 10.89% |
$2,796,696
$110.98 p/Share
|
Jan 31
2025 |
|
BBIO
|
Viking Global Investors LP |
SELL
Open market or private sale
|
Indirect | 3,065,616 Reduced 0.0% |
$106,989,998
$34.9 p/Share
|
Jan 31
2025 |
|
BENF
|
Jeff Welday
Officer |
SELL
Open market or private sale
|
Direct | 170 Reduced 0.11% |
$105
$0.62 p/Share
|
Jan 31
2025 |
|
CDXS
|
Opaleye Management Inc.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 45,000 Added 0.0% |
$193,050
$4.29 p/Share
|
Jan 31
2025 |
|
UNOV
|
Yovan Arturo Sanchez
Director |
BUY
Open market or private purchase
|
Direct | 100,000 Added 6.23% |
$18,000
$0.18 p/Share
|
Jan 31
2025 |
|
SVCC
|
Stellar V Sponsor LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 365,000 Added 50.0% |
-
|
Jan 31
2025 |
|
SVCC
|
George Syllantavos
Co-CEO and CFO |
BUY
Open market or private purchase
|
Indirect | 365,000 Added 0.0% |
-
|
Jan 31
2025 |
|
SVCC
|
Prokopios Akis Tsirigakis
CEO, President and COB |
BUY
Open market or private purchase
|
Indirect | 365,000 Added 0.0% |
-
|
Jan 31
2025 |
|
MRVI
|
Kurt Oreshack
General Counsel |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 12.98% |
$125,750
$5.03 p/Share
|
Jan 31
2025 |
|
SLB
|
Bejar Carmen Rando
Chief People Officer |
SELL
Open market or private sale
|
Direct | 5,524 Reduced 15.2% |
$223,224
$40.41 p/Share
|
Jan 31
2025 |
|
TDUP
|
Patricia Nakache |
SELL
Open market or private sale
|
Indirect | 137,076 Reduced 0.0% |
$304,308
$2.22 p/Share
|
Jan 31
2025 |
|
GOOG
|
Kavitark Ram Shriram |
SELL
Open market or private sale
|
Direct | 14,000 Reduced 4.44% |
$2,870,000
$205.0 p/Share
|
Jan 31
2025 |
|
GOOG
|
Kavitark Ram Shriram |
SELL
Open market or private sale
|
Indirect | 12,000 Reduced 0.0% |
$2,460,000
$205.0 p/Share
|
Jan 31
2025 |
|
AGBAR
|
Robert E. Diamond Jr. |
SELL
Open market or private sale
|
Indirect | 50,000 Reduced 0.0% |
$96,000
$1.92 p/Share
|
Jan 31
2025 |
|
HBT
|
Fred L Drake
Executive Chairman |
SELL
Open market or private sale
|
Indirect | 5,055 Reduced 0.0% |
$125,414
$24.81 p/Share
|
Jan 31
2025 |
|
OTLC
|
Vuong Trieu
CHAIRMAN AND CEO |
BUY
Open market or private purchase
|
Direct | 63,775 Added 0.07% |
$1,913
$0.03 p/Share
|
Jan 31
2025 |
|
HGTY
|
Robert I Kauffman
Director |
SELL
Open market or private sale
|
Indirect | 4,453 Reduced 0.0% |
$43,283
$9.72 p/Share
|
Jan 31
2025 |
|
TDY
|
Robert Mehrabian
Executive Chairman |
SELL
Open market or private sale
|
Direct | 5,768 Reduced 3.84% |
$2,988,689
$518.15 p/Share
|
Jan 31
2025 |
|
BHRB
|
Gary L Hinkle
Director |
BUY
Open market or private purchase
|
Indirect | 1,000 Added 0.0% |
$64,480
$64.48 p/Share
|
Jan 31
2025 |
|
NWBI
|
Timothy M Hunter
Director |
BUY
Open market or private purchase
|
Direct | 10,000 Added 5.51% |
$131,300
$13.13 p/Share
|
Jan 31
2025 |
|
ENBP
|
Nicholas D Klein
Chief Risk Officer |
SELL
Open market or private sale
|
Direct | 500 Reduced 6.99% |
$8,770
$17.54 p/Share
|
Jan 31
2025 |
|
NRIM
|
Shauna Hegna
Director |
BUY
Open market or private purchase
|
Direct | 113 Added 50.0% |
$9,492
$84.0 p/Share
|
Jan 31
2025 |
|
TEM
|
Eric P Lefkofsky
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 77,626 Reduced 1.36% |
$4,240,708
$54.63 p/Share
|
Jan 30
2025 |
|
ATEC
|
Patrick Miles
CEO |
SELL
Open market or private sale
|
Direct | 43,313 Reduced 0.7% |
$521,055
$12.03 p/Share
|
Jan 30
2025 |
|
ALKS
|
Craig C. Hopkinson
EVP R&D, Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 100,918 Reduced 69.5% |
$3,234,421
$32.05 p/Share
|
Jan 30
2025 |
|
BOH
|
Taryn L Salmon
Vice Chair |
SELL
Open market or private sale
|
Direct | 449 Reduced 4.35% |
$33,661
$74.97 p/Share
|
Jan 30
2025 |
|
SKYH
|
Boston Omaha Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 10,587 Reduced 0.1% |
$117,833
$11.13 p/Share
|
Jan 30
2025 |
|
WEAV
|
Blake G Modersitzki |
SELL
Open market or private sale
|
Indirect | 59,964 Reduced 0.0% |
$990,005
$16.51 p/Share
|
Jan 30
2025 |
|
HOPE
|
Thomas Stenger
SEVP, Chief Risk Officer |
SELL
Open market or private sale
|
Direct | 4,185 Reduced 17.84% |
$49,508
$11.83 p/Share
|
Jan 30
2025 |
|
PLXS
|
Angelo Michael Ninivaggi Jr
Exec VP, CAO, Gen Coun & Secy |
SELL
Open market or private sale
|
Direct | 3,423 Reduced 10.4% |
$498,388
$145.6 p/Share
|
Jan 30
2025 |
|
ABT
|
Hubert L Allen
EXECUTIVE VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 58,428 Reduced 24.02% |
$7,482,873
$128.07 p/Share
|
Jan 30
2025 |
|
NPCE
|
Martha Morrell
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 200 Reduced 0.23% |
$3,000
$15.0 p/Share
|
Jan 30
2025 |
|
BENF
|
Jeff Welday
Officer |
SELL
Open market or private sale
|
Direct | 306 Reduced 0.2% |
$189
$0.62 p/Share
|
Jan 30
2025 |
|
CDXS
|
Opaleye Management Inc.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 20,000 Added 0.0% |
$89,800
$4.49 p/Share
|
Jan 30
2025 |
|
ABT
|
Daniel Gesua Sive Salvadori
EXECUTIVE VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 23,771 Reduced 15.9% |
$3,054,573
$128.5 p/Share
|
Jan 30
2025 |
|
NTRS
|
Jason J. Tyler
President/Wealth Management |
SELL
Open market or private sale
|
Direct | 2,237 Reduced 3.69% |
$252,042
$112.67 p/Share
|
Jan 30
2025 |
|
AUBN
|
David E Housel |
BUY
Open market or private purchase
|
Direct | 200 Added 2.4% |
$4,384
$21.92 p/Share
|
Jan 30
2025 |
|
ALK
|
Andrea L Schneider
SVP PEOPLE |
SELL
Open market or private sale
|
Direct | 1,830 Reduced 8.27% |
$134,175
$73.32 p/Share
|
Jan 30
2025 |
|
TEAM
|
Michael Cannon Brookes
CEO, Co-Founder |
SELL
Open market or private sale
|
Indirect | 7,948 Reduced 0.0% |
$2,120,049
$266.74 p/Share
|
Jan 30
2025 |
|
TEAM
|
Scott Farquhar |
SELL
Open market or private sale
|
Indirect | 7,948 Reduced 0.0% |
$2,120,049
$266.74 p/Share
|
Jan 30
2025 |
|
TDUP
|
Patricia Nakache |
SELL
Open market or private sale
|
Indirect | 79,223 Reduced 0.0% |
$175,082
$2.21 p/Share
|
Jan 30
2025 |